NeurAxis Stock (NASDAQ:NRXS)
Previous Close
$3.02
52W Range
$1.33 - $6.20
50D Avg
$2.85
200D Avg
$2.52
Market Cap
$27.53M
Avg Vol (3M)
$372.36K
Beta
3.19
Div Yield
-
NRXS Company Profile
NeurAxis, Inc. operates as a neuromodulation therapy device company in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome healthcare companies primarily hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.